Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Resomelagon
Cat. No.:
OB0425LY-154
Appearance:
Solid
Purity:
99.63%
Identity:
Confirmed by NMR and LC-MS.
Size:
Add to basket
Product Overview
Description:
Resomelagon is a CB1 receptor antagonist with some metabolic modulatory properties.
Synonyms:
1809420-71-0; AP1189; (2E)-2-((2E)-3-(1-(2-Nitrophenyl)-1H-pyrrol-2-yl)prop-2-en-1-ylidene)hydrazine-1-carboximidamide; Hydrazinecarboximidamide, 2-((2E)-3-(1-(2-nitrophenyl)-1H-pyrrol-2-yl)-2-propen-1-ylidene)-, (2E)-
CAS No.:
1809420-71-0
Compound CID:
23728926
Formula:
C14H14N6O2
Formula Weight:
298.3
Specification
Target:
Melanocortin receptor
Pathway:
GPCR/G protein; Neuronal signaling
Solubility:
DMSO
Storage:
Storage at 4°C.
Applications:
Resomelagon is primarily used to study metabolic diseases, especially obesity and related diabetes, to improve metabolic health and to improve weight management.
